Artificial Intelligence News and Research

Latest Artificial Intelligence News and Research

BrainScope receives second consecutive nomination for 2018 Prix Galien USA Awards

BrainScope today announced its second consecutive nomination for the 2018 Annual Prix Galien USA Awards for "Best Medical Technology" product.

2 Aug 2018

New automation software cuts time taken for radiation therapy planning

Beating cancer is a race against time. Developing radiation therapy plans -- individualized maps that help doctors determine where to blast tumors -- can take days.

2 Aug 2018

New AI approach can teach itself to design new drug molecules from scratch

An artificial-intelligence approach created at the University of North Carolina at Chapel Hill Eshelman School of Pharmacy can teach itself to design new drug molecules from scratch and has the potential to dramatically accelerate the design of new drug candidates.

1 Aug 2018

New technology can help people with hearing loss better understand speech

Future hearing aid users will be able to target their listening more accurately thanks to new Danish technology. A researcher from Aalborg University uses machine learning to teach a computer programme how to remove unwanted noise and enhance speech.

30 Jul 2018

New UCI center seeks to empower patients, providers through use of AI in healthcare

Physicians at the University of California, Irvine and UCI Health System have launched the UCI Center for Artificial Intelligence in Diagnostic Medicine, which seeks to advance patient care, improve health outcomes and lower costs by leveraging machine learning technology in all areas of healthcare.

27 Jul 2018

DFG to honor two researchers with Ursula M. Händel Animal Welfare Prize

Prof. Dr. Ellen Fritsche, a toxicologist from the Leibniz Research Institute for Environmental Medicine at Heinrich Heine University Düsseldorf, and PD Dr. Dr. Hamid Reza Noori, a mathematician, physicist and medical scientist from the Max Planck Institute for Biological Cybernetics in Tübingen, are to be presented with the Ursula M. Händel Animal Welfare Prize by the Deutsche Forschungsgemeinschaft.

27 Jul 2018

Artificial intelligence used to demonstrate link between personality and eye movements

It's often been said that the eyes are the window to the soul, revealing what we think and how we feel. Now, new research reveals that your eyes may also be an indicator of your personality type, simply by the way they move.

27 Jul 2018

New analytics platform predicts and monitors chronic autoimmune conditions

IQuity, a Nashville-based data analytics company that specializes in predicting, detecting and monitoring chronic disease, today announced the launch of a revolutionary data mining and analytics platform that will predict and monitor chronic diseases within large populations.

26 Jul 2018

Erlanger Health System partners with Viz.ai to transform stroke care

Erlanger Health System, a multi-hospital health system based in Tennessee have announced a partnership with Viz.ai., a leading applied artificial intelligence company, to transform stroke care.

25 Jul 2018

New data shows that simple blood test accurately diagnoses Peripheral Artery Disease

Prevencio, Inc., announces the publication of data that demonstrates a simple new blood test accurately diagnoses significant Peripheral Artery Disease, a circulatory problem in which plaque-narrowed arteries reduce blood flow to a patient's limbs and kidneys.

25 Jul 2018

Doctors' ‘gut feelings’ play key role in medical decision making, finds study

Many technology companies are working on artificial intelligence systems that can analyze medical data to help diagnose or treat health problems. Such systems raise the question of whether this kind of technology can perform as well as a human doctor.

23 Jul 2018

Top AI companies join hands to discover novel drugs for DMD

Insilico Medicine a leader in artificial intelligence for drug discovery, biomarker development and aging research, announced a research collaboration agreement with A2A Pharmaceuticals, Inc. A2A is a biotechnology company headquartered in New York and focused on development of novel drugs for unmet needs in oncology, drug resistant bacterial infections, and other life threatening diseases.

20 Jul 2018